Letters to the Editor
Exercise-Induced Bronchospasm vs. Exercise-Induced Asthma
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2004 Feb 15;69(4):808-809.
to the editor: I enjoyed reading the article1 in American Family Physician on exercise-induced bronchospasm (EIB). It is apparent that more knowledge and patient education are needed about this prevalent and under-diagnosed condition. I would like to clarify the difference between EIB and exercise-induced asthma (EIA). Although the difference between them has not been fully elucidated, EIB is a bronchospastic disorder, and EIA is an inflammatory condition. As the authors state, “80 to 90 percent of patients with asthma also have EIB.”1 In addition, 5 to 10 percent of patients with EIB have no concomitant respiratory or allergic disease.
Studies on EIB are lacking. Two studies2,3 examined subjects after exercise and were unable to document increased inflammation on bronchoalveolar lavage or in blood histamine levels. This evidence suggests that EIB may not have an inflammatory base.
Other researchers have included patients with chronic asthma in studies determining the efficacy of treatment of EIB. This erroneous inclusion has led to the assumption that anti-inflammatories, such as inhaled steroids, help patients with EIB, when, in actuality, they help patients with EIA.
Although this sounds like semantics, I think it is important to properly define the terms. Diagnosing patients with asthma and initiating anti-inflammatory therapy still can be associated with stigmas, inability to enter military professions, and changes of insurance premiums. It also can be confusing for patients to hear they have “exercise-induced asthma” (a chronic disease) when in truth they only have “exercise-induced bronchospasm” (a transient problem). As more research is done to elucidate the relationship between EIA and EIB, we can better define the terms and appropriate treatments.
1. Sinha T, David AK. Recognition and management of exercise-induced bronchospasm. Am Fam Physician. 2003;67:769–74.
2. Jarjour NN, Calhoun WJ. Exercise-induced asthma is not associated with mast cell activation or airway inflammation. J Allergy Clin Immunol. 1992;89:60–8.
3. Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med. 2000;161:2086–91.
IN REPLY: We thank Dr. Hermansen for raising the issue of the differences between exercise-induced asthma (EIA) and exercise-induced bronchospasm (EIB). The terms EIA and EIB often are used interchangeably in the literature. In our review of the literature we were unable to discover a consensus regarding the pathophysiology of EIA, EIB, and the relationship, if any, between the two terms. Therefore, we have chosen to follow the National Asthma Education and Prevention Program (NAEPP) guidelines,1 in which the expert panel has preferred the term EIB and has used the functional definition of EIB rather than a pathophysiologic one. Currently, there are several theories that attempt to explain the mechanism of EIB. The two with the most consensus are the thermal and osmolarity theories.
The thermal theory is based on the assumption that hyperventilation during exercise causes loss of heat and drying of the airways that in turn causes a transient bronchoconstrictive response.2 The osmolarity theory3 suggests that it is the heat lost during exercise and the rapid rewarming of the airways after exercise that causes a reactive hyperemia of the microvasculature and edema of the airways that sets up an osmotic gradient, which stimulates the release of proinflammatory substances from mast cell and other inflammatory cells. This therapy could possibly explain why steroids and other anti-inflammatory agents4–6 have been shown to improve symptoms in patients with EIB.
As Dr. Hermansen has noted, more research is needed to elucidate the pathophysiology of EIB. Because our article was in the series “Practical Therapeutics,” we stayed away from too many details regarding pathophysiology.
1. National Asthma Education and Prevention Program (National Heart, Lung, and Blood Institute). Guidelines for the diagnosis and management of asthma: expert panel report 2. National Institutes of Health, National Heart, Lung, and Blood Institute. NIH publication no. 97–4051. Bethesda, Md.: U.S. Dept. of Health and Human Services, Public Health Service, 1997.
2. Langdeau JB, Boulet LP. Prevalence and mechanism of development of asthma and airway hyperresponsiveness in athletes. Sports Med. 2001;31:601–16.
3. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is…. J Allergy Clin Immunol. 2000;106:453–9.
4. Cavallo A, Cassaniti C, Glogger A, Magrini H. Action of nedocromil sodium in exercise-induced asthma in adolescents. J Investig Allegol Clin Immunol. 1995;5:286–8.
5. Kelly KD, Spooner CH, Rowe BH. Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: a systematic review. Eur Respir J. 2001;17:39–45.
6. Henriksen JM, Dahl R. Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise-induced asthma. Am Rev Respir Dis. 1983;128:993–7.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: firstname.lastname@example.org, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions